Prothena (NASDAQ:PRTA) Downgraded by Jefferies Financial Group to “Hold”
Prothena (NASDAQ:PRTA – Get Free Report) was downgraded by stock analysts at Jefferies Financial Group from a “buy” rating to a “hold” rating in a report issued on Tuesday, Marketbeat Ratings reports. They presently have a $6.00 price target on the biotechnology company’s stock. Jefferies Financial Group’s target price indicates a potential upside of 30.43% […]
Prothena (NASDAQ:PRTA – Get Free Report) was downgraded by stock analysts at Jefferies Financial Group from a “buy” rating to a “hold” rating in a report issued on Tuesday, Marketbeat Ratings reports. They presently have a $6.00 price target on the biotechnology company’s stock. Jefferies Financial Group’s target price indicates a potential upside of 30.43% […]
